Preventive Health Platform Loovi Raises €1M
Stockholm-based Loovi has secured €1 million in funding to scale its preventive health and longevity platform. The investment underscores continued European investor interest in startups focused on healthspan optimization and preventative care models.
- Loovi's platform integrates data from blood analysis of over 60 biomarkers, physical tests, and user wearables to create a personalized health plan, which is then interpreted by an AI-powered intelligence layer. - The company was co-founded by CEO Joel Grajcer and Dr. Kevin Najafi, a model that combines business leadership with medical expertise to build credibility and trust with health-conscious consumers. - The funding round included notable angel investors such as Susanne Najafi of BackingMinds and Sïmon Saneback from Wellstreet, and the capital is earmarked for platform development, hiring, and market rollout. - For consumer health apps like Loovi that collect data directly from users, compliance often falls under the FTC's authority regarding consumer privacy rather than HIPAA, unless the app partners with a covered healthcare entity. - The growth strategy for retention in similar successful health apps, like Flo and Noom, often relies on creating a data feedback loop where the more information a user logs, the more personalized and valuable the guidance becomes, a model Loovi appears to be following. - The investment in Loovi is part of a larger European trend, with over €21 million recently invested in similar AI-driven preventive health startups, including Switzerland's Aeon (€8.2M) and France's Lucis (€7.2M). - To foster user trust beyond technology, Loovi's platform includes human interaction, providing members with video consultations with doctors and access to a team of nutritionists, personal trainers, and physiotherapists. - Loovi emphasizes data privacy by complying with GDPR and storing all user data encrypted on servers located in Sweden.
